Loading…
Anlon Healthcare (AHCL)₹26.93−3.23%Pharmaceuticals
Anlon Healthcare is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 42.1 against a peer median of 31.9, and ROCE of 21.0% against a peer median of 21.0%, and latest-quarter sales growth of 103.7% against a peer median of 11.5%. By market cap it is #6 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Venus Remedies | 1,941 | 15.9 | 21.0 | 15.7 | 0.02 | 0.7 | 769 | 103 | 13.3 | 30.0 | vs AHCL |
| Syncom Formulations (India) | 1,885 | 21.6 | 27.1 | 20.2 | 0.00 | 0.5 | 488 | 76 | 7.7 | 56.3 | vs AHCL |
| Amrutanjan Health Care | 1,502 | 26.0 | 25.0 | 18.5 | 0.00 | 1.1 | 503 | 58 | 11.0 | 6.6 | vs AHCL |
| Accent Microcell | 1,446 | 33.0 | 25.0 | 18.7 | 0.00 | 0.2 | 349 | 44 | 51.1 | 52.9 | vs AHCL |
| Jagsonpal Pharmaceuticals | 1,433 | 31.9 | 23.0 | 17.3 | 0.03 | 1.8 | 287 | 43 | 9.5 | 0.1 | vs AHCL |
| Anlon Healthcare | 1,433 | 42.1 | 21.0 | 18.4 | 0.19 | 0.0 | 173 | 29 | 103.7 | 89.0 | — |
| Fermenta Biotech | 1,267 | 21.2 | 21.0 | 16.4 | 0.28 | 0.9 | 524 | 70 | −10.7 | −55.8 | vs AHCL |
| Kopran | 1,252 | 50.0 | 7.0 | 4.9 | 0.29 | 1.2 | 683 | 26 | 13.9 | −10.0 | vs AHCL |
| Bajaj Healthcare | 1,062 | 54.5 | 10.9 | 9.4 | 0.47 | 0.5 | 608 | 16 | 11.5 | 16.5 | vs AHCL |
| Lincoln Pharmaceuticals | 1,043 | 10.8 | 16.0 | 12.0 | 0.01 | 0.3 | 672 | 88 | 17.3 | 0.0 | vs AHCL |
| Sigachi Industries | 1,036 | 38.2 | 6.0 | 5.8 | 0.27 | 0.4 | 478 | −83 | −5.4 | — | vs AHCL |
| Peer median | 1,433 | 31.9 | 21.0 | 16.4 | 0.03 | 0.5 | 503 | 44 | 11.5 | 11.5 |
Listed companies closest to Anlon Healthcare in Pharmaceuticals include Venus Remedies, Syncom Formulations (India), Amrutanjan Health Care, Accent Microcell, Jagsonpal Pharmaceuticals, Fermenta Biotech, Kopran, Bajaj Healthcare.
Venus Remedies, with a market cap of ₹1,941 Cr.
Anlon Healthcare trades at a P/E of 42.1; the median of its peer set is 31.9. A P/E above or below the median is a description, not a judgement on value.
Anlon Healthcare's return on capital employed is 21.0%, below the peer median of 21.0%.